8.30 Registration & Welcome Coffee

8:50 am Opening Remarks

Elevating Novel Lipid Chemistry to Create the Winning Vehicle

9:10 am From Liposomes to LNPs: Evaluating the Lipid-Based Delivery Technology Landscape

  • Rajesh Shinde Senior Director of Manufacturing & Technology Operations , Genprex


  • Navigating the complex landscape of lipid-based nanoparticle delivery
  • Delving into LNPs, liposomes, polymeric LNPs, phospholipids and more
  • Evaluating the current limitations of these lipid technologies

9:30 am Expanding Current Capabilities for Intracellular Drug Delivery with a Lipid Nano-Crystal (LNC) Platform


  • What are LNCs and how do they deliver drugs?
  • How they can improve delivery, reduce toxicity, avoid immunogenicity and even allow oral administration
  • Preclinical and clinical validation

10.00 Structured Networking & Morning Coffee Break


This session is the perfect opportunity to get face-to-face time with the key opinion leaders in lipid-based delivery.
Establish meaningful business relationships to build upon for the rest of the conference and gain individual insight into the pioneering work ongoing.

11:00 am Developing Targeted Lipid Nanoparticles (tLNPs) to Enable Off-the-Shelf Immunotherapies


  • Transforming immunotherapy by enabling the reprogramming of immune cells in vivo
  • Designing tLNPs for targeted delivery for oncology, fibrosis and inflammation-related diseases
  • Tight control of dosage and of activity of engineered cells to achieve an advanced, first-in-class therapeutic

11:30 am Polymer Lipid Hybrids: A Chemical Toolbox for LNP Formulations

  • Vincent Nebot Chief Technical Officer , Polypeptide Therapeutic Solutions (PTS)


  • Novel polymer-lipids, beyond PEG
  • Advantages of Polysarcosine PSar
  • Lipid Manufacturing
  • LNP Manufacturing

11:40 am Next-Generation Lipid Nanoparticle Technologies Enabling (Extra) Hepatic Nucleic Acid Delivery


  • Platform technologies tailored to a variety of tissues
  • Improved potency and safety
  • Scalable, nucleic acid agnostic, based on GRAS substances

12:10 pm Session Reserved for: Precision Nanosystem

12.40 Lunch Break


Take this chance to meet the expert speakers, connect with your peers and explore our exhibition booths

Cultivating the Most Effective Journey of the Lipid-Based Vehicle in the Body

1:30 pm Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver


  • Hear the latest insights on delivering to extrahepatic cells and tissues using lipid-based nanoparticles
  • Explore the current opportunities for the industry and how this is expected to change over the next 5 years
  • How can we leverage the lessons learned and in depth research on delivery to the liver to expand our progress and meet unmet patient needs?

2:15 pm Using High-Throughput LNP Screening to Identify Novel Non-Liver Delivery Vehicles

  • Kalina Paunovska Postdoctoral Scholar Dahlman Lab , Georgia Institute of Technology


  • High-throughput LNP screening allows us to screen for many LNPs at once in vivo
  • Utilizing high-throughput screening to identify non-liver LNPs
  • Identifying novel chemical compounds through high-throughput screening

14.45 Afternoon Break & Poster Networking Session


Grab a coffee and explore this scientific poster session to see the latest developments, pioneering research and exciting breakthroughs on lipid-based nanoparticles delivery.

Maximizing Therapeutic Potential Through Optimized Administration

3:15 pm Roundtable: Elevating Patient Centric Administration


Join this roundtable discussion to:

  • Discuss the challenge of balancing patient comfort with the easiest route of administration
  • Debate the advantages and limitations of different administration including IV, oral and vaccines
  • Develop a patient friendly processes to allow continuous administration

3:45 pm Formulation & Delivery Challenges with Inhaled Lipid Nanoparticle Formulations


  • What lipid nanoparticle formulations are amenable to inhaled delivery?
  • What are the considerations in choosing a delivery system to target the lung?
  • What assays and methodologies are used to characterize aerosolization of lipid nanoparticles?

4:15 pm Spray Drying of Lipid Nanoparticles Enables Intratracheal Delivery

  • Kristina Friis Senior Scientist, Advanced Drug Delivery , AstraZeneca


  • Diving into the key parameters required to facilitate spray drying of LNPs
  • Enhancing LNP stability, cellular uptake and RNA delivery to the lung
  • Potential for future applications including inhaled vaccines


4:45 pm Closing Remarks & End of Day One

17.00 Poster Networking Session


The networking and learning continues with this scientific poster networking session. Connect with your peers in a relaxed atmosphere to continue forging and growing your new relationships.